Wearable Activity Tracking to Curb Hospitalizations (WATCH)
Sponsor: University of California, San Francisco
Trial Details
| Condition | Hematopoietic Neoplasm, Malignant Solid Neoplasm, Lymphatic System Neoplasm |
| Intervention | Fitbit; Apple HealthKit-based devices |
| Status | Recruiting |
| Participants | 260 |
| Est. Completion | 31 Dec 2027 |
| Last Updated | 17 Apr 2026 |
Primary Outcome
Area under the receiver operating characteristic curve (AUC-ROC) of the step count model; Calculation of a Brier Score; Calculation of Log-Loss Score; Area Under the Precision-Recall Curves (AUCPR)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age \>= 18. * Eastern Cooperative Oncology Group (ECOG) performance status =\< 2. * Able to understand study procedures and to comply with them for the entire length of the study. * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. * Diagnosis of invasive malignancy. * Able to ambulate independently (without the assistance of a cane or walker). * Planned treatment with fractionated external beam radiotherapy over at least 5 days (no fractional requirement). * Not a previous participant on this protocol for subsequent courses. Exclusion Criteria: * Participants bound to a wheelchair. * Participants unable to ambulate independently (needing assistance of cane or walker).
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service